Get your EU MDR 2017/745 gap analysis and CE transition strategy

Europe's new Medical Devices Regulation 2017/745 (MDR) takes effect in May. With manufacturers all over the world transitioning to the MDR and ISO 13485:2016, Notified Body staff shortages and work backlogs are likely to cause delays.

We can identify the best MDD-to-MDR transition strategy for your company based on your product range, certification cycle, the markets you serve, and your Notified Body.

Emergo by UL's scalable transition strategy include:

EU MDR 2017/745 Gap Assessment and CE Transition Strategy for Medical Device
European Authorized Representative for Medical Device Companies
European Post-Market Clinical Follow-up Studies (PMCF) for Medical Devices
On-Site Medical Devices Regulation (EU MDR) Training for Manufacturers
MEDDEV 2.7.1 rev 4 and Clinical Evaluation Reports (CER) for Medical Devices
EU MDR compliance consulting for cosmetic and aesthetic products

Don't put it off. Contact us today to learn how we can help you transition to new EU Medical Device Regulation.

Please contact me for my complimentary needs assessment

By submitting this form I am agreeing to receive periodic emails from UL LLC (UL), Emergo, and affiliates containing best practices, education, industry research, news, updates and promotions related to UL’s products and services. I understand that I can unsubscribe at any time and agree to UL’s Online Policies.

Please add to your email’s Safe Senders List to prevent UL's emails from being sent to your spam folder.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.